EcoFlex – User Guide

To provide the user with details for customizable modification of plasmids, we provide details of cloning procedures used.

ORFs

ORFs can be amplified by PCR from plasmid or genomic DNA, or synthesised to remove rare codons and excluded restriction sites (NdeI, BamHI, BsaI, BsmBI). Alternatively, genes with internal NdeI and BamHI sites can be PCR amplified with primers containing flanking BsaI sites or sub-cloned using an optional NcoI (CCATGG) site located in pBP-ORF, which also provides a start codon. Additionally, if BamHI is present within a gene, the 3’ primer can incorporate a BglII site, which forms cohesive overhangs with BamHI.

Bioparts

Users can customize the library with alternative DNA parts (promoters, RBS, tags etc) using the pBP-lacZa plasmid. Whilst we provide N-terminal His6 and Strep(II) tags; further fusion tags such as C-terminal extensions and fluorescence or probe tags can be custom built.

Plasmid purification and sequencing

Single colonies were grown overnight with antibiotic in 3-5 mL LB in a 50 mL Falcon. All plasmids were purified with a QIAprep Spin Miniprep kit and eluted with 50-100 μL of sterile (pre-heated 65°C for plasmids larger than 10 kb) distilled water to obtain ~60-200 ng/ul dsDNA. The yield varies depending on insert size, whilst decreased yields can be obtained with the promoter parts (SJM901 and SJM911) that exhibit toxicity from the GFP reporter.

Oligo annealing

Annealing primers were prepared at 20 mM in 25 m of 1 × T4 DNA ligase buffer (10 × NEB), heated to 90°C for 1 min, before cooling on ice. Annealed primers were phosphorylated with T4 Polynucleotide kinase for 1 hour at 37°C before dilution to 200 nM and ligation into the backbone plasmid. Standard ligations were prepared in 2 × Rapid Ligation buffer (Promega) and T4 DNA ligase (Promega) at room temperature for 30 min. Ligation mixtures were transformed into DH10b, JM109 or KRX chemically competent cells. For routine Level 1 transformations, DH10b competent cells were prepared with the calcium chloride method. For Level 2 transformations, commercial competent cells were used (competency 108 CFU/mg).

Golden Gate Reaction – Level 1

20 units of BsaI-HF (NEB), 1-3 units of T4 DNA ligase (Promega) was combined with 10X ligase buffer (Promega) and 1 mg mL-1 BSA. 50 ng of “destination vector” and 100 ng of “entry vectors” were combined in a one-pot reaction and cycled 15 times with 5 min at 37 °C and 10 min 16 °C. This was followed by 5 min incubations at 50°C and 80°C.

Golden Gate Reaction – Level 2

10 units of BsmBI (NEB), 1-3 units of T4 DNA ligase (Promega) was combined with 10X ligase buffer (Promega) and 1 mg mL-1 BSA. 50 ng of “destination vector” and 100 ng of “entry vectors” were combined in a one-pot reaction and incubated at 37°C for 16 hours. This was followed by a 5 min incubation at 80°C. Alternatively a 30 cycle protocol equivalent to Level 1 assembly can be used. This increases the total number of colonies obtained, but the percentage of correct clones decreases when using GFP as a positive marker for a 5 TU assembly.

Golden Gate Reaction – Level 3

20 units of BsaI-HF (NEB), 1-3 units of T4 DNA ligase (Promega) was combined with 10X ligase buffer (Promega) and 1 mg mL-1 BSA. 50 ng of “destination vector” and 100 ng of “entry vectors” were combined in a one-pot reaction and cycled 30 times with 5 min at 37°C and 10 min 16°C. This was followed by 5 min incubations at 50°C and 80°C.

Secondary module cloning

A Level 2 unit containing 2, 3, 4 or 5 TUs can be sub-cloned with BsaI into two cohesive BpiI sites located in pTUS-A, -a and –b. The assembled plasmid is then ready for standard Level 2 assembly to accommodate up to 10 TUs.

EcoFlex kit plasmids – Assembly plasmids and “Destination Vectors”

Level 0

pBP-lacZ (#72948)

Promoters, RBS, Tags and terminators ligated between NdeI and SphI

ATCTAGAGACGCATATG-lacZa-GCATGCCGTCTCATTAG

pBP-ORF (#72949)

Open reading frames cloned between NdeI and BamHI

GGTCTCACATATGGGTTCCATGGGGCACGGATCCTCGAAGAGACC

Level 1 -[NM]- Negative marker rfp or lacZa fragment

pTU1-A (#72935 and #72939)

CGTCTCAATCTCTATAGAGACC-[NM]-GGTCTCATGTTTGCCAGAGACG

pTU1-B (#72936 and #72940)

CGTCTCATGCCCTATAGAGACC-[NM]-GGTCTCATGTTCCGGAGAGACG

pTU1-C (#72937 and #72941)

CGTCTCACCGGCTATAGAGACC-[NM]-GGTCTCATGTTGAAGAGAGACG

pTU1-D (#72938 and #72942)

CGTCTCAGAAGCTATAGAGACC-[NM]-GGTCTCATGTTTTAGAGAGACG

pTU1-D1 (#72943)

CGTCTCAGAAGCTATAGAGACC-[NM]-GGTCTCATGTTCTTCAGAGACG

pTU1-E (#72944)

CGTCTCACTTCCTATAGAGACC-[NM]-GGTCTCATGTTTTAGAGAGACG

Level 2

pTU2-A (#72950 and #72954)

GGTCTCACTATATCTAGAGACG-[NM]-CGTCTCATTAGGTACAGAGACC

pTU2-B (#72951 and #72955)

GGTCTCAGTACATCTAGAGACG-[NM]-CGTCTCATTAGGGACAGAGACC

pTU2-C (#72952 and #72956)

GGTCTCAGGACATCTAGAGACG-[NM]-CGTCTCATTAGTCGAAGAGACC

pTU2-D (#72953 and #72957)

GGTCTCATCGAATCTAGAGACG-[NM]-CGTCTCATTAGTGTTAGAGACC

pTU2-a (#72958)

GGTCTCACTATATCTAGAGACG-[RFP]-CGTCTCACCGGGTACAGAGACC

pTU2-b (#72959)

GGTCTCACTATATCTAGAGACG-[RFP]-CGTCTCAGAAGGTACAGAGACC

Level 3

pTU3-A – 2 fragments from Level 2 (#72945)

CGTCTCAATCTCTATAGAGACC-[RFP]-GGTCTCAGGACTTAGAGAGACG

pTU3-B – 4 fragments from Level 4 (#72946)

CGTCTCAATCTCTATAGAGACC-[RFP]-GGTCTCATGTTTTAGAGAGACG

Secondary module (Level 2) site – (pTU2S-a, -b and –A)

#73010 – pTU2S-a (pMB1 origin) Accepts 2 TUs

#73011 – pTU2S-b (pMB1 origin) Accepts 3 TUs

Placed between AatI and EcoRI sites in pTU2–A, pTU2-a and pTU2-b. Modules from pTU2-A are sub-cloned (by gel extraction) as a BsaI fragment into the compatible BpiI sites. NdeI and SphI are placed between the BpiI sites for further modification and spacing between the restriction sites.

CTATAAGTCTTCCATATGCACGCATGCGAAGACAAGTAC

Biological Parts

Promoters

J23100 (#72963)

CTATTTGACGGCTAGCTCAGTCCTAGGTACAGTGCTAGCGTAC

J23108 (#72964)

CTATCTGACAGCTAGCTCAGTCCTAGGTATAATGCTAGCGTAC

J23114 (#72965)

CTATTTTATGGCTAGCTCAGTCCTAGGTACAATGCTAGCGTAC

SJM901 (#72966)

CTATTTTACAGCTAGCTCAGTCCTAGGTATAATGCTAGCGTAC

SJM902 (#72967)

CTATTTTACAGCTAGCTCAGTCCTAGGGATTATGCTAGCGTAC

SJM903 (#72968)

CTATCTTATAGCTAGCTCAGTCCTTGGGATTATGCTAGCGTAC

SJM905 (#72969)

CTATTTTATAGCTAGCTCAGTCCTTGGGATTATGCTAGCGTAC

SJM906 (#72970)

CTATTTGATGGCTAGCTCAGTCCTAGGGATTGTGCTAGCGTAC

SJM908 (#72971)

CTATTTTATAGCTAGCTCAGCCCTTGGTATTATGCTAGCGTAC

SJM910 (#72972)

CTATTTGATGGCTAGCTCAGTCCTTGGTATTATGCTAGCGTAC

SJM911 (#72973)

CTATTTGACAGCTAGCTCAGTCCTTGGTACTGTGCTAGCGTAC

SJM912 (#72974)

CTATTTGATAGCTAGCTCAGTCCTAGGTACTATGCTAGCGTAC

SJM915 (#72976)

CTATTTTATGGCTAGCTCAGTCCTTGGTATTATGCTAGCGTAC

T7 consensus (#72977)

CTATTAATACGACTCACTATAGGGAGAGTAC

T7 promoter and PET RBS combinations

T7 promoter, lac operator and PET RBS (#72978)

CTATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATA

T7 promoter, lac operator, PET RBS, His6-tag and thrombin site (#72989)

CTATCCCGCGAAATTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATA

RBS, linkers and tags

BBa_B0034 (#72980)

GTACAAAGAGGAGAAACATA

PET RBS (#72981)

GTACTTTAACTTTAAGAAGGAGATATACATA

N-terminus tag-linker (#72982)

GTACTTTAACTTTAAGAAGGAGATATATAAA

Hexahistidine (#72983)

TAAATGCACCATCACCATCACCATA

Strep(II) (#72984)

TAAATGTGGAGCCACCCGCAGTTCGAAAAACCGCATA

TL1 (#72985)

GTACAGATCTAATAATTTTGTTTAACTTTGGGGGGATACATA

TL2 (#72986)

GTACAGATCTAATAATTTTGTTTAACTTTGGGAGGATACATA

TL3 (#72987)

GTACAGATCTAATAATTTTGTTTAACTTTGGGGGAATACATA

TL4 (#72988)

GTACAGATCTAATAATTTTGTTTAACTTTAAGGAGATACATA

TL5 (#72989)

GTACAGATCTAATAATTTTGTTTAACTTTGGAGAAATACATA

TL6 (#72990)

GTACAGATCTAATAATTTTGTTTAACTTTGGGGAAATACATA

TL7 (#72991)

GTACAGATCTAATAATTTTGTTTAACTTTAGGGGAATACATA

TL8 (#72992)

GTACAGATCTAATAATTTTGTTTAACTTTAAAGAGATACATA

TL9 (#72993)

GTACAGATCTAATAATTTTGTTTAACTTTAAAAAGATACATA

TL10 (#72994)

GTACAGATCTAATAATTTTGTTTAACTTTGAAAAAATACATA

TL11 (#72995)

GTACAGATCTAATAATTTTGTTTAACTTTAAAGGGATACATA

TL12 (#72996)

GTACAGATCTAATAATTTTGTTTAACTTTGGGAAGATACATA

Open reading frames

GFP (#72960)

CATATGCGTAAAGGAGAAGAACTTTTCACTGGAGTTGTCCCAATTCTTGTTGAATTAGATGGTGATGTTAATGGGCACAAATTTTCTGTCAGTGGAGAGGGTGAAGGTGATGCAACATACGGAAAACTTACCCTTAAATTTATTTGCACTACTGGAAAACTACCTGTTCCATGGCCAACACTTGTCACTACTTTCGGTTATGGTGTTCAATGCTTTGCGAGATACCCAGATCATATGAAACAGCATGACTTTTTCAAGAGTGCCATGCCCGAAGGTTATGTACAGGAAAGAACTATATTTTTCAAAGATGACGGGAACTACAAGACACGTGCTGAAGTCAAGTTTGAAGGTGATACCCTTGTTAATAGAATCGAGTTAAAAGGTATTGATTTTAAAGAAGATGGAAACATTCTTGGACACAAATTGGAATACAACTATAACTCACACAATGTATACATCATGGCAGACAAACAAAAGAATGGAATCAAAGTTAACTTCAAAATTAGACACAACATTGAAGATGGAAGCGTTCAACTAGCAGACCATTATCAACAAAATACTCCAATTGGCGATGGCCCTGTCCTTTTACCAGACAACCATTACCTGTCCACACAATCTGCCCTTTCGAAAGATCCCAACGAAAAGAGAGAGCACATGGTCCTTCTTGAGTTTGTAACAGCTGCTGGGATTACACATGGCATGGATGAACTATACAAATAATCGA

CFP (#72961)

CATATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTGGGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACATCAGCCACAACGTCTATATCACCGCCGACAAGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCTAAGGATCCTCGA

mCherry (#72962)

CATATGGTGAGCAAGGGCGAGGAGGATAACATGGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCTTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACATCAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGAGGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTAAGGATCCTCGA

iGEM terminators

BBa_B0012 (#72997)

TCGATCACACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATATGTT

BBa_B0015 (#72998)

TCGACCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAAGACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGAACGCTCTCTACTAGAGTCACACTGGCTCACCTTCGGGTGGGCCTTTCTGCGTTTATATGTT

Synthetic terminators

L3S2P21 (#72999)

TCGACTCGGTACCAAATTCCAGAAAAGAGGCCTCCCGAAAGGGGGGCCTTTTTTCGTTTTGGTCCTGTT

L3S1P51 (#73000)

TCGAAAAAAAAAAAAAGGCCTCCCAAATCGGGGGGCCTTTTTTATTGATAACAAAATGTT

L3S1P32 (#73001) – BsmBI site underlined

TCGAGACGAACAATAAGGCCTCCCAAATCGGGGGGCCTTTTTATTTTTCAACAAAATGTT

L3S1P11 (#73002) – BsmBI site underlined

TCGAGACGAACAATAAGGCCTCCCTTCGGGGGGGCCTTTTTTATTGATAACAAAATGTT

L2U8H11 (#73003)

TCGATAGCGTGCTAACCACGCACGCTATTGTTGTATTGTT

L2U5H11 (#73004)

TCGATAGCGTGCGAACAGCACGCTATTGTTGTATTGTT

L2U5H08 (#73005)

TCGATGCCGGGAGAACATCCCGGCATTGTTGTATTGTT

L2U3H03 (#73006)

TCGATAGCGTGACCGGCGCATCGGTCACGCTATTTGTTGAGTGTT

L2U2H09 (#73007)

TCGAACGGCCCTCGCAAGGGCCGTTTTTTTGTATGTT

L1U1H09 (#73008)

TCGACGACGATGTTCGCATCGTCGTTTTTTTTTTGTT

L1U1H08 (#73009)

TCGACCCGCATGTTCGCATGCGGGTTTTTTTTTTGTT

Individual plasmids

Secondary module (Level 2) site – (pTU2S-a, -b and –A)

#74088 – pTU2S-a (p15A origin) Accepts 2 TUs

#74089 – pTU2S-b (p15A origin) Accepts 3 TUs

#74090 – pTU2S-A (p15A origin) Accepts 4-5 TUs

#74091 – pTU2S-a (colE1 origin) Accepts 2 TUs

#74092 – pTU2S-b (colE1 origin) Accepts 3 TUs

#74093 – pTU2S-A (colE1 origin) Accepts 4-5 TUs

Lactate promoter - Bba_K822000 (#74094)

CTATCACATTCCTATAGGCCGAGTAAGGTGTTCACGCCGCATCCGGCAAGATAAGGCGCTCTGGATCAACAACCTAAGGGCAATTCTCTGATGAGGATTGCCCTTTTCTTTACCAGACATCTCCCCCCACAAGAATTGGCCCTACCAATTCTTCGCTTATCTGACCTCTGGTTCACAATTTCCCAATTAAAACTCACATCAATGTTGCCAATACATAACATTTAGTTAACCATTCATTGTCATTATCCCTACACAACACAATTGGCAGTGCCACTTTTACACAACGTGTGACAAGGAGATGAGCAACAGACTCATTACACGATGTGCGTGGACTCCGTAC

lldR – E. coli MG1655 (#74095)

CATATGATTGTTTTACCCAGACGCCTGTCAGACGAGGTTGCCGATCGTGTGCGGGCGCTGATTGATGAAAAAAACCTGGAAGCGGGCATGAAGTTGCCCGCTGAGCGCCAACTGGCGATGCAACTCGGCGTATCACGTAATTCACTGCGCGAGGCGCTGGCAAAACTGGTGAGTGAAGGCGTGCTGCTCAGTCGACGCGGCGGCGGGACGTTTATTCGCTGGCGTCATGACACATGGTCGGAGCAAAACATCGTCCAGCCGCTAAAAACACTGATGGCCGATGATCCGGATTACAGTTTCGATATTCTGGAAGCCCGCTACGCCATTGAAGCCAGCACCGCATGGCATGCGGCAATGCGCGCCACACCTGGCGACAAAGAAAAGATTCAGCTTTGCTTTGAAGCAACGCTAAGTGAAGACCCGGATATCGCCTCACAAGCGGACGTTCGTTTTCATCTGGCGATTGCCGAAGCCTCACATAACATCGTGCTGCTGCAAACCATGCGCGGTTTCTTCGATGTCCTGCAATCCTCAGTGAAGCATAGCCGTCAGCGGATGTATCTGGTGCCACCGGTTTTTTCACAACTGACCGAACAACATCAGGCTGTCATTGACGCCATTTTTGCCGGTGATGCTGACGGGGCGCGTAAAGCAATGATGGCGCACCTTAGTTTTGTTCACACCACCATGAAACGATTCGATGAAGATCAGGCTCGCCACGCACGGATTACCCGCCTGCCCGGTGAGCATAATGAGCATTCGAGGGAGAAAAACGCATAAGGATCCTCGA

T7 RNA polymerase (#74096)

CATATGaacacgattaacatcgctaagaacgacttctctgacatcgaactggctgctatcccgttcaacactctggctgaccattacggtgagcgtttagctcgcgaacagttggcccttgagcatgagtcttacgagatgggtgaagcacgcttccgcaagatgtttgagcgtcaacttaaagctggtgaggttgcggataacgctgccgccaagcctctcatcactaccctactccctaagatgattgcacgcatcaacgactggtttgaggaagtgaaagctaagcgcggcaagcgcccgacagccttccagttcctgcaagaaatcaagccggaagccgtagcgtacatcaccattaagaccactctggcttgcctaaccagtgctgacaatacaaccgttcaggctgtagcaagcgcaatcggtcgggccattgaggacgaggctcgcttcggtcgtatccgtgaccttgaagctaagcacttcaagaaaaacgttgaggaacaactcaacaagcgcgtagggcacgtctacaagaaagcatttatgcaagttgtcgaggctgacatgctctctaagggtctactcggtggcgaggcgtggtcttcgtggcataaggaagactctattcatgtaggagtacgctgcatcgagatgctcattgagtcaaccggaatggttagcttacaccgccaaaatgctggcgtagtaggtcaagactctgagactatcgaactcgcacctgaatacgctgaggctatcgcaacccgtgcaggtgcgctggctggcatctctccgatgttccaaccttgcgtagttcctcctaagccgtggactggcattactggtggtggctattgggctaacggtcgtcgtcctctggcgctggtgcgtactcacagtaagaaagcactgatgcgctacgaagacgtttacatgcctgaggtgtacaaagcgattaacattgcgcaaaacaccgcatggaaaatcaacaagaaagtcctagcggtcgccaacgtaatcaccaagtggaagcattgtccggtcgaggacatccctgcgattgagcgtgaagaactcccgatgaaaccggaagacatcgacatgaatcctgaggctctcaccgcgtggaaacgtgctgccgctgctgtgtaccgcaaggacaaggctcgcaagtctcgccgtatcagccttgagttcatgcttgagcaagccaataagtttgctaaccataaggccatctggttcccttacaacatggactggcgcggtcgtgtttacgctgtgtcaatgttcaacccgcaaggtaacgatatgaccaaaggactgcttacgctggcgaaaggtaaaccaatcggtaaggaaggttactactggctgaaaatccacggtgcaaactgtgcgggtgtcgataaggttccgttccctgagcgcatcaagttcattgaggaaaaccacgagaacatcatggcttgcgctaagtctccactggagaacacttggtgggctgagcaagattctccgttctgcttccttgcgttctgctttgagtacgctggggtacagcaccacggcctgagctataactgctcccttccgctggcgtttgacgggtcttgctctggcatccagcacttctccgcgatgctccgagatgaggtaggtggtcgcgcggttaacttgcttcctagtgaaaccgttcaggacatctacgggattgttgctaagaaagtcaacgagattctacaagcagacgcaatcaatgggaccgataacgaagtagttaccgtgaccgatgagaacactggtgaaatctctgagaaagtcaagctgggcactaaggcactggctggtcaatggctggcttacggtgttactcgcagtgtgactaagcgttcagtcatgacgctggcttacgggtccaaagagttcggcttccgtcaacaagtgctggaagataccattcagccagctattgattccggcaagggtctgatgttcactcagccgaatcaggctgctggatacatggctaagctgatttgggaatctgtgagcgtgacggtggtagctgcggttgaagcaatgaactggcttaagtctgctgctaagctgctggctgctgaggtcaaagataagaagactggagagattcttcgcaagcgttgcgctgtgcattgggtaactcctgatggtttccctgtgtggcaggaatacaagaagcctattcagacgcgcttgaacctgatgttcctcggtcagttccgcttacagcctaccattaacaccaacaaagatagcgagattgatgcacacaaacaggagtctggtatcgctcctaactttgtacacagccaagacggtagccaccttcgtaagactgtagtgtgggcacacgagaagtacggaatcgaatcttttgcactgattcacgactccttcggtaccattccggctgacgctgcgaacctgttcaaagcagtgcgcgaaactatggttgacacatatgagtcttgtgatgtactggctgatttctacgaccagttcgctgaccagttgcacgagtctcaattggacaaaatgccagcacttccggctaaaggtaacttgaacctccgtgacatcttagagtcggacttcgcgttcgcgtaaTCGA